WE ARE CURRENTLY FULLY ENROLLED FOR THIS STUDY

 

However, we still want to hear from you. If your dog has atopic dermatitis, email us at info@vetcelltherapeutics.com.

 

Does your dog have symptoms of Canine Atopic Dermatitis – Constant itching or licking, red skin, loss of fur?

Purpose: Our goal is to help dogs suffering from atopic dermatitis (AD) by determining if stem cells can serve as a safe, effective and extended treatment alternative from corticosteroids and/or other medical treatment strategies.

Description: This pilot clinical study will examine the role of allogenic canine adipose mesenchymal stem cells in treatment of AD in companion dogs. AD is an inflammatory skin disease, characterized by varying degrees of itching, and is associated with environmental allergies. Approximately 10% of dogs suffer from AD and currently all fast-acting symptomatic therapies need frequent administration and can be associated with serious adverse effects. Your pet will be followed closely by our veterinarians to ensure they are happy and comfortable throughout the study. After stem cell administration, we will perform blood tests and monitor the patient for improvements in their itching and other skin lesions.

Client benefits:

  • Health screening i.e. blood work, skin scraping, fungal culture and skin cytologies
  • Topical flea and tick preventatives (for the duration of the study)
  • Potential improvement of the pet’s atopic dermatitis condition

Inclusion criteria:
Participants must be:

  • Healthy (excluding the presence of atopic dermatitis)
  • On effective flea control
  • 1+ years of age
  • At least 4/9 body condition score
  • Under 100lbs

Things to note:

  • Enrolled patients will be maintained on a commercial hypoallergenic diet throughout the duration of study
  • Participants with a history of medication must observe a withdrawal period for:
    • Cytopoint®, Apoquel® & all glucocorticoids (topical, injectable & oral) – 8 weeks
    • Cyclosporine – 4 weeks
    • Oral antihistamines – 2 weeks

(Topical/oral antimicrobial therapies for secondary infections may be continued, as needed)

  • During the study, the pet’s diet must remain consistent. Administration of over-the- counter medications will require a consultation with the research team veterinarians

For further questions regarding this clinical study, please contact:
Western University Pet Health Center (909) 865-2433
Principal Veterinarian Investigator: Dr. Gagandeep Kaur DVM PhD

Copyright © 2017 PrimeGen Biotech, LLC

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. VetCell Therapeutics makes no representation and assumes no responsibility for the accuracy of information contained on or available through this web site, and such information is subject to change without notice.

You are encouraged to confirm any information obtained from or through this web site with other sources, and review all information regarding any medical condition or treatment with your physician.

NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH ANY WEB SITE.